Stephanie Lee Trowbridge, | |
800 N Justice St, Hendersonville, NC 28791 | |
(828) 696-1000 | |
(828) 696-1314 |
Full Name | Stephanie Lee Trowbridge |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 800 N Justice St, Hendersonville, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801187612 | NPI | - | NPPES |
NCK362D | Other | NC | MEDICARE PTAN |
P02005431 | Other | NC | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 91433 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephanie Lee Trowbridge, 2421 Baslow Dr, Apex, NC 27539-9062 Ph: (843) 458-0110 | Stephanie Lee Trowbridge, 800 N Justice St, Hendersonville, NC 28791 Ph: (828) 696-1000 |
News Archive
According to a study published Thursday, a brief screening in a pediatrician's office can detect autism-like symptoms in children as young as 12 months old, giving them an important head start on treatment. The screening test used in the study also flagged some babies who later turned out to be developing normally, raising a false alarm for families. But early diagnosis and treatment of autism and other developmental delays are thought to improve outcomes, and researchers said the benefits of early intervention outweighed the downsides.
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer.
Depomed, Inc. (NASDAQ: DEPO) announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-795.
Researchers in the United States have conducted a study showing that activation of the complement system is specifically implicated in the pathogenesis of severe coronavirus disease 2019 (COVID-19), rather than being a broader indicator of critical illness.
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
› Verified 2 days ago
Dr. Mark Robinson Chandler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 | |
Dr. Roger Clay Vanarsdell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 275 Canterbury Way, Hendersonville, NC 28792 Phone: 828-681-1839 | |
Robert J. Bryant, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 Thompson St Ste A, Hendersonville, NC 28792 Phone: 828-697-3232 Fax: 828-698-0125 | |
Gary R Whitaker, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 212 Thompson St Ste A, Hendersonville, NC 28792 Phone: 828-697-3232 | |
Gabriela Ursin, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 | |
Clinton W Hamrick, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 212a Thompson St, Hendersonville, NC 28792 Phone: 828-697-3232 Fax: 828-698-0125 | |
Dr. Serena Famatta York, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 N Justice St, Hendersonville, NC 28791 Phone: 828-696-1000 Fax: 828-696-1314 |